What development phase is Phenyltrimethicone in?

Phenyltrimethicone is FDA-approved (marketed).

What is the generic name of Phenyltrimethicone?

phenyl trimethicone is the generic (nonproprietary) name of Phenyltrimethicone.

Last reviewed 2026-04-20 · How we verify

Phenyltrimethicone (phenyl trimethicone)

FDA-approved active Quality 6/100

Phenyl trimethicone is a marketed product that forms a protective barrier on the skin's surface to improve texture and appearance. Its key strength lies in its ability to enhance skin texture, which differentiates it in the cosmetic and dermatological markets. The primary risk is the expiration of the key composition patent in 2028, which could lead to increased competition from generics.

At a glance

Generic name	phenyl trimethicone
Therapeutic area	Dermatology
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Phenyltrimethicone CI brief — competitive landscape report
Phenyltrimethicone updates RSS · CI watch RSS
portfolio CI